Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Article	Citations
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice	193
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia	61
Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota	42
Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction	32
SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study	32
Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patients	32
Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: A meta-analysis of cohort studies	29
Prevalence of hypertensive disorders in pregnancy in China: A systematic review and meta-analysis	26
Heart rate variability in hypertensive pregnancy disorders: A systematic review	25
Effects of statins on preeclampsia: A systematic review	24
LncRNA MALAT1 affects the migration and invasion of trophoblast cells by regulating FOS expression in early-onset preeclampsia	23
Community-level interventions for pre-eclampsia (CLIP) in Pakistan: A cluster randomised controlled trial	23
Impact of preconception sodium intake on hypertensive disorders of pregnancy: The Japan Environment and Children’s study	22
Renin-angiotensin system in normal pregnancy and in preeclampsia: A comprehensive review	21
Community-level interventions for pre-eclampsia (CLIP) in Mozambique: A cluster randomised controlled trial	20
Postpartum blood pressure trends are impacted by race and BMI	20
Community level interventions for pre-eclampsia (CLIP) in India: A cluster randomised controlled trial	20
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study	19
Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity	19
Circulating pregnancy hormone relaxin as a first trimester biomarker for preeclampsia	19
Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes	17
Overlapping pathogenic signalling pathways and biomarkers in preeclampsia and cardiovascular disease	17
Decidual mesenchymal stem/stromal cell-derived extracellular vesicles ameliorate endothelial cell proliferation, inflammation, and oxidative stress in a cell culture model of preeclampsia	17
Successful implementation of text-based blood pressure monitoring for postpartum hypertension	16
The role of tumor necrosis factor in triggering activation of natural killer cell, multi-organ mitochondrial dysfunction and hypertension during pregnancy	15

Blood pressure postpartum (BP2) RCT protocol: Follow-up and lifestyle behaviour change strategies in the first 12 months after hypertensive pregnancy	15
Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial	14
Esomeprazole and sulfasalazine in combination additively reduce sFlt-1 secretion and diminish endothelial dysfunction: potential for a combination treatment for preeclampsia	14
Hypertension in pregnancy: Prevalence, risk factors and outcomes for women birthing in Ireland	13
Neuropathophysiology of preeclampsia and eclampsia: A review of cerebral hemodynamic principles in hypertensive disorders of pregnancy	13
Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: The PEACOCK study	13
Resveratrol and grape juice: Effects on redox status and nitric oxide production of endothelial cells in in vitro preeclampsia model	13
Prediction of adverse maternal outcomes of early severe preeclampsia	12
Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease	12
Preeclampsia among women with COVID-19 during pregnancy and its impact on maternal and perinatal outcomes: Results from a national multicenter study on COVID in Brazil, the REBRACO initiative	12
Apocynin inhibits placental TLR4/NF-κB signaling pathway and ameliorates preeclampsia-like symptoms in rats	12
How digital health affects the patient-physician relationship: An empirical-ethics study into the perspectives and experiences in obstetric care	11
Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in Norway	11
sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19	11
Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension	11
SAFE@HOME: Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia	11
sFlt-1/PlGF ratio for the prediction of delivery within 48 hours and adverse outcomes in expectantly managed early-onset preeclampsia	11
Increased TLR4 pathway activation and cytokine imbalance led to lipopolysaccharide tolerance in monocytes from preeclamptic women	11
Methylene tetrahydrofolate reductase and methionine synthase gene polymorphisms as genetic determinants of pre-eclampsia	11
The sFlt-1/PlGF ratio as a triage tool to identify superimposed preeclampsia in women with chronic hypertension in emergency rooms	11
Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium	11
Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study	11
Identifying new potential genetic biomarkers for HELLP syndrome using massive parallel sequencing	10
Relative impact of pre-eclampsia on birth weight in a low resource setting: A prospective cohort study	10
Who said differentiating preeclampsia from COVID-19 infection was easy?	10
Elevated immunoexpression of interferon-gamma in placenta tissue samples from pregnancies complicated with preeclampsia compared to the placenta previa	10
MiR-384 inhibits proliferation and migration of trophoblast cells via targeting PTBP3	10
Role of sFlt-1/PIGF ratio and uterine Doppler in pregnancies with chronic kidney disease suspected with Pre-eclampsia or HELLP syndrome	10
Risk factors associated with gestational diabetes mellitus: The role of pregnancy-induced hypertension and physical inactivity	10
Tumor Necrosis Factor-alpha Blockade Improves Uterine Artery Resistance, Maternal Blood Pressure, and Fetal Growth in Placental Ischemic Rats	10
Novel electronic health records applied for prediction of pre-eclampsia: Machine-learning algorithms	10
Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction	10
Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio	10
Changes to management of hypertension in pregnancy, and attitudes to self-management: An online survey of obstetricians, before and following the first wave of the COVID-19 pandemic	9
First trimester elevations of hematocrit, lipid peroxidation and nitrates in women with twin pregnancies who develop preeclampsia	9
Gestational weight gain and adverse pregnancy outcomes by pre-pregnancy BMI category in women with chronic hypertension: A cohort study	9
Differences in hair cortisol concentrations and reported anxiety in women with preeclampsia versus uncomplicated pregnancies	9
Association of Aquaporin-3, Aquaporin-7, NOS3 and CYBA polymorphisms with hypertensive disorders in women	9
Protein-creatinine ratio and albumin-creatinine ratio for the diagnosis of significant proteinuria in pregnant women with hypertension: Systematic review and meta-analysis of diagnostic test accuracy	9
Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study	9
Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications	9
Mitochondrial DNA copy number variation – A potential biomarker for early onset preeclampsia	9
Flavonoids exert potential in the management of hypertensive disorders in pregnancy	9
Maternal diseases and risk of hypertensive disorders of pregnancy across gestational age groups	9
Standardising definitions for the pre-eclampsia core outcome set: A consensus development study	9
Hypertensive disorders in pregnancy – Trends over eight years: A population-based cohort study	8
Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats	8
Identification of potential crucial genes associated with early-onset preeclampsia via bioinformatic analysis	8
Increased NDRG1 expression suppresses angiogenesis via PI3K/AKT pathway in human placental cells	8
Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia	8

Elevated expression of galectin-3, thioredoxin and thioredoxin interacting protein in preeclampsia	8
Screening for Primary Aldosteronism in Pregnancy	8
Cardiac dysfunction after preeclampsia; an overview of pro- and anti-fibrotic circulating effector molecules	8
The predictive value of sonographic placental markers for adverse pregnancy outcome in women with chronic kidney disease	7
Preeclampsia, gestational hypertension and incident dementia: A systematic review and meta-analysis of published evidence	7
The effect of calcium supplementation on blood pressure in non-pregnant women with previous pre-eclampsia: A randomized placebo-controlled study	7
The non-traditional and familial risk factors for preeclampsia in the FINNPEC cohort	7
Changes in proteinuria and diagnosing preeclampsia in CKD pregnancy	7
Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis	7
Fetal growth restriction as a diagnostic criterion for preeclampsia	7
Validation of the fullPIERS model for prediction of adverse outcomes in preeclampsia at a referral center	7
Selective serotonin reuptake inhibitors and preeclampsia: A quality assessment and meta-analysis	7
Histopathological features of kidney and renal prognosis in patients with preeclampsia	7
Predictors of posterior reversible encephalopathy syndrome in women with hypertension in pregnancy: A prospective observational study	7
Congo red dot test in the early prediction and diagnosis of pre-eclampsia in a tertiary health care centre in India	7
Hypoproteinemia as a parameter of poor perinatal/neonatal outcomes in women with preeclampsia diagnosed as hypertension plus proteinuria	7
Preconception dietary inflammatory index and hypertension disorders of pregnancy: The Japan environment and children's study	7
Factors associated with attendance at the postpartum blood pressure visit in pregnancies complicated by hypertension	7
Neuroradiological perspectives of severe preeclampsia and eclampsia spectrum – Correlation from posterior reversible encephalopathy syndrome	7
Preeclampsia and low sodium: A retrospective cohort analysis and literature review	6
Alterations in maternal sFlt-1 and PlGF: Time to labor onset in term-/late-term pregnancies with and without placental dysfunction	6
Weight gain in early, mid, and late pregnancy and hypertensive disorders of pregnancy	6
Self-monitoring of blood pressure in pregnancy: A mixed methods evaluation of a national roll-out in the context of a pandemic	6
Cardiovascular mortality risk a decade after twin and singleton pregnancies complicated by hypertensive disorders of pregnancy	6
Metabolic syndrome following hypertensive disorders in pregnancy in a low-resource setting: A cohort study	6
Comprehensive transcriptome mining identified the gene expression signature and differentially regulated pathways of the late-onset preeclampsia	6
Adherence with blood pressure self-monitoring in women with pregnancy hypertension, and comparisons to clinic readings: A secondary analysis of OPTIMUM-BP	6
Angiogenic markers during preeclampsia: Are they associated with hypertension 1 year postpartum?	6
Hypertension in pregnancy as a possible factor for child autistic behavior at two years old	6
Transcription factor ID1 is involved in decidualization of stromal cells: Implications in preeclampsia	6
Maternal preeclampsia and long-term infectious morbidity in the offspring – A population based cohort analysis	6
Diagnosis of placental insufficiency independently of clinical presentations using sFlt-1/PLGF ratio, including SGA patients	6
17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats	6
Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio	6
Preeclampsia and the crucial postpartum period for Covid-19 infected mothers: A case report	6
Aberrant corin and PCSK6 in placentas of the maternal hyperinsulinemia IUGR rat model	6
Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe	6
Prehypertension as a risk factor for the development of perinatal complications: Retrospective cohort study	6
Pre-eclampsia is associated with later kidney chronic disease and end-stage renal disease: Systematic review and meta-analysis of observational studies	6
Maternal and neonatal complications in women with medical comorbidities and preeclampsia	6
Adherence to anti-hypertensive medication in pregnancy	6
Neutrophil extracellular traps: The synergy source in the placentae of HIV infected women with pre-eclampsia	6
Correlation between corin, N-terminal pro-atrial natriuretic peptide and neonatal adverse prognostic in hypertensive disorders of pregnancy	5
Do modifiable risk factors for cardiovascular disease post-pregnancy influence the association between hypertensive disorders of pregnancy and cardiovascular health outcomes? A systematic review of ob	5
Pregnancy outcomes in women with hyponatraemia and preeclampsia: Case series and literature review	5
Good performance of bioimpedance in early pregnancy to predict preeclampsia	5
Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women	5
Subclinical cardiac performance in obese and overweight women as a potential risk factor of preeclampsia	5
Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010–2019	5
Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia – A qualitative study	5
Preeclampsia and high blood pressure in early pregnancy as risk factors of severe maternal cardiovascular disease during 50-years of follow-up	5
Epidemiology of pre-eclampsia in the Republic of Kazakhstan: Maternal and neonatal outcomes	5
Clinical factors associated with preeclampsia recurrence	5
Low birth weight and abnormal pre-pregnancy body mass index were at higher risk for hypertensive disorders of pregnancy	5
Association of glutamate cystein ligase (GCL) activity Peroxiredoxin 4 (prxR4) and apelin levels in women with preeclampsia	5
Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers’ perspective	5
Nomogram-based prediction of pre-eclampsia in the first trimester of gestation	5
Rule-in thresholds for DELFIA Xpress PlGF 1-2-3 test for suspected pre-eclampsia	5
The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study	5
Stage 1 hypertension defined by the 2017 ACC/AHA guidelines and neonatal outcomes: Systematic review and meta-analysis	5
Role of sFLT-1/PlGF ratio in predicting severe adverse materno-fetal outcome in high risk women	5
Increased urinary albumin leakage is related to injuries of glomerular glycocalyx and podocytes, and associated with tubular dysfunction in preeclampsia	5
Low-dose aspirin increases 15-epi-lipoxins A4 in pregnancies at high-risk for developing preeclampsia	5
Efficacy of low-dose nicardipine for emergent treatment of severe postpartum hypertension in maternal intensive care units: An observational study	5
Angiogenic factors and prediction for ischemic placental disease in future pregnancies	5
Differential regulation of a placental SAM68 and sFLT1 gene pathway and the relevance to maternal vitamin D sufficiency	5
Diagnostic accuracy of urine dipstick tests for proteinuria in pregnant women suspected of preeclampsia: A systematic review and meta-analysis	5
Determining psychological distress during pregnancy and its association with the development of a hypertensive disorder	5
High blood pressure at entry into antenatal care and birth outcomes among a cohort of HIV-uninfected women and women living with HIV initiating antiretroviral therapy in South Africa	5
Maternal and umbilical cord procalcitonin, high-sensitivity C-reactive protein, and interleukin-6 levels in preeclamptic and normotensive patients: A cross-sectional study	5
Effect of blood pressure control in early pregnancy and clinical outcomes in African American women with chronic hypertension	4
Preeclampsia and eclampsia: Its burden and distribution across facilities in Ethiopia	4
What is the role of glycemic control in the development of preeclampsia among women with type 1 diabetes?	4
A point-of care urine test to predict preeclampsia development in Asian women with suspected preeclampsia	4
Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study	4
Relevance of maternal sodium level for preeclampsia-associated adverse pregnancy outcomes	4
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial	4
Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy	4
Uncaria tomentosa extract (AC-11) improves pregnancy hypertension together with suppression of sFlt-1 and sEng	4
The predictive value of signs and symptoms in predicting adverse maternal and perinatal outcomes in severe preeclampsia in a low-resource setting, findings from a cross-sectional study at Mpilo Centra	4

Plasma CD59 concentrations are increased in preeclampsia with severe features and correlate with laboratory measures of end-organ injury	4
Higher gestational weight gain and lower serum estradiol levels are associated with increased risk of preeclampsia after in vitro fertilization	4
Maternal low birth weight and hypertensive disorders of pregnancy	4
Transcription factor AP2A affects sFLT1 expression and decidualization in decidual stromal cells: Implications to preeclampsia pathology	4
Hypertensive diseases in pregnancy, cardiac structure and function later in life: Insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study	4
Acute pulmonary edema due to severe preeclampsia in advanced maternal age women	4
Maternal macro- and micronutrient intake six months after hypertensive versus normotensive pregnancy: is poor diet quality contributing to future cardiometabolic disease risk?	4
Incidence of essential hypertension but not echocardiographic abnormalities at four years with a history of preeclampsia with severe features	4
Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia	4
Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia	4
Small extracellular vesicles from plasma of women with preeclampsia increase myogenic tone and decrease endothelium-dependent relaxation of mouse mesenteric arteries	4
Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies	3
Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States	3
Factors associated with poor fetal outcome in placental abruption	3
Dental amalgams and risk of gestational hypertension in the MIREC study	3
Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy	3
Preconception ovarian reserve and placenta-mediated pregnancy complications among infertile women	3
A cohort study of antihypertensive use during pregnancy in South Korea, 2013–2017	3
Why magnesium sulfate ‘coverage’ only is not enough to reduce eclampsia: Lessons learned in a middle-income country	3
Functional and structural vascular biomarkers in women 1 year after a hypertensive disorder of pregnancy	3
Pregnancy in patients with stage 3–5 CKD: Maternal and fetal outcomes	3
Eclampsia with RCVS: Postpartum seizure provoked by methergine	3
Reduction of serum-induced endothelial STAT3(Y705) activation is associated with preeclampsia	3
Healthy and preeclamptic pregnancies show differences in Guanylate-Binding Protein-1 plasma levels	3
Development and external validation of a model for predicting adverse outcomes in women with preeclampsia: A retrospective study from two trans-regional centers in China	3
Lower blood pressure achieved leads to better pregnant outcomes in non-severe chronic hypertensive pregnant women	3
The impact of obesity on haemodynamic profiles of pregnant women beyond 34 weeks’ gestation	3
Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management	3
Eclampsia in Italy: A prospective population-based study (2017–2020)	3
Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study	3
Characteristics of preeclampsia in donor cell gestations	3
Utero-placental vascular remodeling during late gestation in Sprague-Dawley rats	3
Change in prevalence of chronic hypertension in pregnancy after the updated ACC/AHA hypertension guidelines	3
Lead exposure and association with angiogenic factors and hypertensive disorders of pregnancy	3
Perinatal outcomes and 2017 ACC/AHA blood pressure categories	3
Longitudinal changes in angiogenesis biomarkers within 72 h of diagnosis and time-to-delivery in early-onset preeclampsia	3
Can the neutrophil-to-lymphocyte ratio (NLR) predicts fetal loss in preeclampsia with severe features?	3
Risk of unplanned healthcare utilization in postpartum period for patients with hypertensive disorders of pregnancy	3
Platelet counts during normal pregnancies and pregnancies complicated with hypertensive disorders	3
Long intergenic ncRNA 00473 improves the invasion of trophoblastic cells via miR-16-5p	3
RUPP Th17s cause hypertension and mitochondrial dysfunction in the kidney and placenta during pregnancy	3
Down-regulation of B2R contributes to preeclampsia by inhibiting human trophoblast cell invasion and angiogenesis	3
Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia	3
Glycyrrhizin potentially suppresses the inflammatory response in preeclampsia rat model	3
Multimodal fusion model for classifying placenta ultrasound imaging in pregnancies with hypertension disorders	3
Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia	3
Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women	3
Clinical implementation of pre-eclampsia screening in the first trimester of pregnancy	3